Nitric oxide decreases motility and increases adhesion in human breast cancer cells

Oncology Reports

Volumn 21, Issue 2, 2009, Pages 275-281

  Lahiri, M ^a   Martin, J H J ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Adhesion; Breast cancer; Metalloproteinase; Motility; Nitric oxide

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; ENZYME INHIBITOR; MATRIX METALLOPROTEINASE; NITRIC OXIDE SYNTHASE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; BREAST TUMOR; CELL MOTION; DRUG EFFECT; FEMALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; FEMALE; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 62849093770     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000218     Document Type: Article

References (46)

1. Baum M and Badwe RA: Does surgery influence the natural history of breast cancer? In: Breast Cancer: Controversies in Management. Wise H and Johnson HJ (eds). Futura, Armonk, NY, pp61-69, 1994.
2. Pass HI: Biology of metastatic disease. Semin Thorac Cardiovasc Surg 14: 10-17, 2002.
3. Williams EL and Djamgoz MB: Nitric oxide and metastatic cell behaviour. Bioessays 27: 1228-1238, 2005.
4. Goligorsky MS, Budzikowski AS, Tsukahara H and Noiri E: Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis. Clin Exp Pharmacol Physiol 26: 269-271, 1999.
5. Goligorsky MS, Noiri E, Peresleni T and Hu Y: Role of nitric oxide in cell adhesion and locomotion. Exp Nephrol 4: 314-321, 1996.
6. Noiri E, Peresleni T, Srivastava N, et al: Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. Am J Physiol 270: C794-C802, 1996.
7. Jadeski LC, Hum KO, Chakraborty C and Lala PK: Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 86: 30-39, 2000.
8. Jadeski LC, Chakraborty C and Lala PK: Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclise and mitogen-activated protein kinase. Int J Cancer 106: 496-504, 2003.
9. Sun Y, Liu J, Oian F and Xu Q: Nitric oxide inhibits T cell adhesion and migration by down-regulation of beta 1-integrin expression in immunologically liver-injured mice. Int Immunopharmacol 6: 616-626, 2006.
10. DalSecco D, Moreira AP, Freitas A, et al: Nitric oxide inhibits neutrophil migration by a mechanism dependent on ICAM-1: role of soluble guanylate cyclise. Nitric Oxide 1: 77-86, 2006.
11. Guo H, Marroquin CE, Wai PY and Kuo PC: Nitric oxide-dependent osteopontin expression induces metastatic behaviour in HepG2 cells. Dig Dis Sci 50: 1288-1298, 2005.
12. Jodele S, Blavier L, Yoon JM and DeClerck YA: Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25: 35-43, 2006.
13. Bjornland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O and Maelandsmo GM: Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res 127: 151-156, 2005.
14. Zhang A, Meng L, Wang Q, et al: Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2. Oncol Rep 15: 831-836, 2006.
15. Upchurch GR, Ford JW, Weiss SJ, et al: Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro. J Vasc Surg 34: 76-83, 2001.
16. Yoshida M, Sagawa N, Itoh H, et al: Nitric oxide increases matrix metalloproteinase-1 production in human uterine cervical fibroblast cells. Mol Hum Reprod 7: 979-985, 2001.
17. Fincham VJ and Frame MC: The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J 17: 81-92, 1998.
18. Nobes CD and Hall A: Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144: 1235-1244, 1999.
19. Schultz RM, Silberman S, Persky B, Bajkowski AS and Carmichael DF: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48: 5539-5545, 1988.
20. Martin JHJ, Alalami O and van den Berg HW: Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence. Cancer Lett 144: 65-74, 1999.
21. Lahiri M and Martin JHJ: Reduced expression of endothelial and inducible nitric oxide synthase in a multi-drug resistant variant of the MCF-7 human breast cancer cell line. Oncol Rep 12: 1007-1011, 2004.
22. Martin JHJ, Begum S, Alalami O, Harrison A and Scott K: Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumor Biol 21: 90-97, 2000.
23. Oka S, Sasada M, Yamamoto K, et al: Nitric oxide derived from human umbilical vein endothelial cells inhibits transendothelial migration of neutrophils. Int J Hematol 81: 220-227, 2005.
24. Harada K, Supriatno K, Kawaguchi S, Tomitaro O, Yoshida H and Sato M: Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. In Vivo 18: 449-455, 2004.
25. Colasanti M and Suzuki H: The dual personality of NO. Trends Pharmacol Sci 21: 249-252, 2000.
26. Lechne M, Lirk P and Rieder J: Inducible nitric oxide synthase (iNOS) in tumour biology: two sides of the same coin. Semin Cancer Biol 15: 277-289, 2005.
27. Thippeswamy T, McKay JS, Quinn JP and Morris R: Nitric oxide, a biological double-faced janus - is this good or bad? Histol Histopathol 21: 445-458, 2006.
28. Jun CD, Han MK, Kim UH and Chung HT: Nitric oxide induces ADP-ribosylation of actin in murine macrophages: association with the inhibition of pseudopodia formation, phagocytic activity, and adherence on a laminin substratum. Cell Immunol 174: 25-34, 1996.
29. Hassid A, Yao J and Huang S: NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation. Am J Physiol 277: H1014-H1026, 1999.
30. Ridnour LA, Thomas DD, Donzelli S, et al: The biphasic nature of nitric oxide responses in tumour biology. Antioxid Redox Signal 8: 1329-1337, 2006.
31. Trachtman H, Futterweit S, Garg SP, Reddy K and Singhal PC: Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem Biophys Res Commun 218: 704-708, 1996.
32. Orucevic A, Bechberger J and Green AM: Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 81: 889-896, 1999.
33. Sasaki K, Hattori T, Fujisawa T, Takahashi K, Inoue H and Takigawa M: Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem 123: 431-439, 1998.
34. Tamura T, Nakanishi T, Kimura Y, et al: Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology 137: 3729-3737, 1996.
35. Ledingham MA, Denison FC, Riley SC and Norman JE: Matrix metalloproteinases-2 and -9 and their inhibitors are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors. Hum Reprod 14: 2089-2096, 1999.
36. Brennan PA and Moncada S: From pollutant gas to biological messenger: the diverse actions of nitric oxide in cancer. Am R Coll Surg Engl 84: 75-78, 2002.
37. Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW and Mitchell JB: The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19: 711-721, 1998.
38. Eberhardt W, Beeg T, Beck KF, et al: Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 57: 59-69, 2000.
39. Eberhardt W, Akool S, Rebhan J, et al: Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability. J Biol Chem 277: 33518-33528, 2002.
40. Gurjar MV, Sharma RV and Bhalla RC: eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol 19: 2871-2877, 1999.
41. Ramomski MW, Palmer RM and Moncada S: Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92: 181-187, 1987.
42. Ramomski MW, Palmer RM and Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057-1058, 1987.
43. de Graff JC, Banga JD, Moncada S, Palmer RM, Groot PG and Sixma JJ: Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85: 2284-2290, 1992.
44. Kong L, Dunn GD, Keefer LK and Korthuis RJ: Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin Exp Metastasis 14: 335-343, 1996.
45. Ivanova K, Poole IC, Gerzar R, Westerhof W and Das PK: Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components. J Pathol 183: 469-476, 1997.
46. Okayama N, Coe L, Itoh M and Alexander J: Exogenous nitric oxide increases neutrophil adhesion to cultured human endothelial monolayers through a protein kinase G dependent mechanism. Inflammation 23: 37-50, 1999.